|
Elan Announces the Suspension of Trading of Its Shares Commencing March 7, 2006 For Up to Two Days; Suspension of Trading Due to Two Day FDA Advisory Committee Meeting to Review Tysabri.
Publication: Business Wire Publication Date: 28-FEB-06 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2006 Business Wire
DUBLIN, Ireland -- Elan Corporation, plc today announced it has agreed with the Irish Stock Exchange (ISE), the Financial Services Authority in the United Kingdom and the New York Stock Exchange (NYSE) to suspend trading of its securities (ADRs and ordinary shares) during the scheduled U.S. Food and Drug...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Business Wire |
Myogen to Present at the Citigroup Small & Mid-Cap Conference.
February 28, 2006
|
UnumProvident Sets Annual Meeting Date.
February 28, 2006
|
Move Over Greenies(R), There's a New Dog Chew in Town; Aspen Pet Produ...
February 28, 2006
|
Suffolk Bancorp Increases Regular Quarterly Dividend by 10 Percent.
February 28, 2006
|
Team NEO Opens Satellite Office in Akron Chamber Offices; Team NEO Sta...
February 28, 2006
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
